958 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Cynosure Group LLC

Cynosure Group LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 958 shares of the company’s stock, valued at approximately $320,000.

Several other institutional investors also recently bought and sold shares of the business. Centerpoint Advisors LLC acquired a new position in HCA Healthcare in the 4th quarter valued at $27,000. Atlantic Edge Private Wealth Management LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth about $27,000. LifeSteps Financial Inc. acquired a new stake in HCA Healthcare in the 1st quarter valued at about $33,000. Northwest Investment Counselors LLC acquired a new position in shares of HCA Healthcare during the 1st quarter worth approximately $36,000. Finally, Rise Advisors LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at approximately $36,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HCA has been the topic of several recent research reports. TD Cowen lowered their price target on shares of HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a research report on Tuesday, April 30th. Oppenheimer raised their target price on HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research note on Monday, April 29th. Wells Fargo & Company raised their price objective on HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 28th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday, June 28th. Finally, Royal Bank of Canada raised their price target on HCA Healthcare from $322.00 to $329.00 and gave the stock an “outperform” rating in a research report on Monday, April 29th. Four equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and an average target price of $327.06.

Insider Buying and Selling

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,863 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total value of $607,673.34. Following the transaction, the senior vice president now directly owns 19,612 shares in the company, valued at approximately $6,397,042.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction on Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the transaction, the executive vice president now owns 34,124 shares in the company, valued at $10,544,316. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Kathryn A. Torres sold 1,863 shares of the company’s stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the transaction, the senior vice president now owns 19,612 shares in the company, valued at $6,397,042.16. The disclosure for this sale can be found here. Insiders have sold a total of 12,397 shares of company stock valued at $3,921,929 over the last quarter. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Stock Up 4.1 %

Shares of HCA stock traded up $13.42 on Tuesday, reaching $338.80. 1,324,209 shares of the stock were exchanged, compared to its average volume of 1,136,309. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $348.00. The business’s 50 day moving average price is $328.15 and its 200 day moving average price is $321.75. The company has a market capitalization of $88.74 billion, a price-to-earnings ratio of 16.81, a PEG ratio of 1.46 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. During the same quarter in the previous year, the firm earned $4.93 earnings per share. The business’s revenue was up 11.2% compared to the same quarter last year. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 20.97 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were issued a $0.66 dividend. The ex-dividend date of this dividend was Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.78%. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.